Business & Financial Update
On November 15, 2013, ULURU, Inc. (OTCQB:ULUR) reported financial results for the third quarter 2013. Revenues for the three month period ending September 30, 2013 totaled $110,580, comprised of $88,904 in products sales, $11,400 in licensing fees, and $10,276 in royalty income. Revenues of $110,580 increased 24% over the third quarter 2013.
Product sales of $88,904 were driven primarily by an increase in new distribution agreements and launching Altrazeal® in various countries around the world. Specifically, during the third quarter 2013, Altrazeal® was shipped to five new markets: Czech Republic, Slovakia, South Africa, Croatia, and Slovenia. Since the beginning of the third quarter 2013, the company has announced the further expansion of the Altrazeal®...
Only subscribers can access this article, which is part of the PRO research library covering 3,573 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: